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Chronic Cough Is Associated With Long Breaks
in Esophageal Peristaltic Integrity on Highresolution Manometry
Michael C Bennett,1 Amit Patel,1,3 Nitin Sainani,1 Dan Wang,4 Gregory S Sayuk,1,2 and C Prakash Gyawali1*
1
Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA; 2Division of Gastroenterology, John Cochran VA
Medical Center Saint Louis, MO, USA; 3Division of Gastroenterology, Duke University School of Medicine and the Durham VA Medical Center,
Durham, NC, USA; and 4Division of Gastroenterology, The First Hospital of Jilin University, Changchung, Jilin, China

Background/Aims
Breaks in the peristaltic contour on esophageal high-resolution manometry (HRM) may be associated with bolus retention in the
esophagus. We evaluated the relationship between peristaltic breaks and esophageal symptoms, reflux exposure, and symptom
outcomes in a prospective patient cohort.
Methods
Two hundred and eighteen patients (53.2 ± 0.9 years, 68.3% female) undergoing both pH-impedance testing and HRM over a 5-year
period were prospectively evaluated. Demographics, symptom presentation, acid exposure time, symptom association probability, and
symptom burden scores were collected. Outcomes were assessed on follow-up using changes in symptom scores. Presence of long
breaks (≥ 5 cm) on HRM was assessed by a blinded author. Relationships between breaks, reflux parameters, presenting symptoms,
and outcomes were assessed.
Results
Patients with long breaks were more likely to have cough as a presenting symptom than those without (43.4% vs 28.6%, P =
0.024); statistical differences were not demonstrated with other symptoms (P ≥ 0.3). Numbers of swallows with long breaks were
higher in patients with cough compared to those without (2.4 ± 0.3 vs 1.6 ± 0.2, P = 0.021); differences were not found with
other symptoms (P ≥ 0.4). Long breaks were not associated with age, gender, race, reflux burden, symptom association, or changes
in symptom metrics (P ≥ 0.1 for all comparisons). Among patients with cough, the presence of long breaks predicted suboptimal
symptom improvement with antireflux therapy (P = 0.018); this difference did not hold true for other symptoms (P ≥ 0.2).
Conclusions
Long breaks in esophageal peristaltic integrity are associated with cough. The presence of long breaks is associated with suboptimal
benefit from antireflux therapy.
(J Neurogastroenterol Motil 2018;24:387-394)
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Introduction

Materials and Methods

Gastroesophageal reflux disease (GERD) commonly presents
with typical symptoms of heartburn and acid regurgitation, but on
occasion, can manifest as atypical symptoms, including chest pain,
cough, and laryngeal symptoms.1 For instance, GERD is the most
common cause of atypical chest pain not due to a cardiac cause,2 and
is believed to be the third most common cause triggering chronic
cough, after post-nasal drip and asthma.3 The likelihood of endoscopic evidence of GERD is much lower with atypical symptoms
when compared to typical symptoms,4 and symptom improvement
from acid suppressive therapy can be suboptimal.5 Therefore, atypical symptoms often require evaluation with esophageal physiologic
tests including ambulatory pH or pH-impedance monitoring (typically performed off antisecretory therapy in the setting of unproven
GERD), and esophageal high-resolution manometry (HRM).1
While it is well known that esophageal hypomotility patterns
are associated with more profound esophageal reflux burden,6 only
limited evidence points towards association of such patterns with
specific GERD symptoms. In particular, the presence of weak
peristalsis with long breaks has been shown to be more prevalent
in patients with chronic cough when compared to heartburn, with
evidence of incomplete bolus transit on stationary impedance in the
setting of breaks.7 The relationship of peristaltic breaks with esophageal symptoms is intriguing, since breaks could potentially allow for
prolonged retention of bolus or refluxate, and the proximal esophagus is known to be more sensitive to bolus presence.8 However, the
associations between symptoms, peristaltic breaks, and symptomatic
outcomes with antireflux therapy remain incompletely understood.
In this study, we evaluated peristaltic breaks on HRM in a
prospective cohort of patients with reflux symptoms undergoing
pH-impedance testing, where reflux burden was well characterized,
and symptom-reflux association was documented. Our aims were:
(1) to assess the prevalence of abnormal motor patterns, particularly
breaks in the peristaltic contour, within patients with typical and
atypical reflux symptoms, (2) to evaluate relationships between
specific esophageal symptoms, reflux burden, and peristaltic breaks
on HRM, and (3) to determine if the presence of peristaltic breaks
predict symptom outcomes with antireflux therapy.
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Subjects
All adult patients (≥ 18 years) with persistent GERD symptoms despite anti-secretory therapy referred to the Gastroenterology Motility Center at Washington University in Saint Louis for
ambulatory pH-impedance testing and HRM from January 2005
through August 2010 were eligible for inclusion. Exclusion criteria
included inadequate studies (poor data quality precluding analysis),
incomplete studies (< 14 hours recording time for pH-impedance,
inadequate swallow complement on HRM), presence of major
esophageal motor disorders (achalasia spectrum disorders, socalled “scleroderma esophagus”), and history of fundoplication or
other foregut surgery. Patients were identified from our institution’s
database and contacted for informed consent; they were prospectively followed up and repeat symptom assessment was performed
by questionnaire. Patient management was not influenced by this
study protocol; instead, management was directed by the referring
physicians. The data-set from which this analysis was performed
has been previously utilized in analyzing GERD phenotypes,9 and
in identifying metrics from pH-impedance testing that predict
GERD symptom response.10,11 This study protocol was approved
by the Human Research Protection Office (institutional review
board) at Washington University in Saint Louis (201105490 approved 6/6/2011). Informed consent was obtained from each patient for collection and analysis of HRM, and pH-impedance and
symptom questionnaire data.

High-resolution Manometry
HRM studies were performed after an overnight fast using a
36-channel solid-state catheter system with high-fidelity circumferential sensors 1 cm apart along the catheter (Covidien/Given Imaging, Duluth, GA, USA). After calibration, the catheter was passed
through an anesthetized nasal canal. A 20-second swallow-free period was obtained while the subject remained still, resting quietly in
the recumbent position (landmark period) from which basal pressures were obtained.12 Ten swallows were recorded using 4-5 mL
of ambient temperature water spaced > 20 seconds apart. Studies
were acquired and analyzed using dedicated computerized HRM
acquisition, display, and analysis systems (ManoView; Covidien/
Given Imaging). A blinded author reviewed HRM studies for
presence and length of breaks in the peristaltic contour of individual
swallows, using the 20 mm isobaric contour tool. Since this study
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was designed to evaluate the role of long breaks, any presence of
breaks, and particularly breaks ≥ 5 cm were recorded (in contrast
to the Chicago classification v3.0 where breaks are not evaluated if
distal contractile integral (DCI) < 450 mmHg∙cm∙sec).13 Swallows
with long breaks (breaks ≥ 5 cm in length) were designated as either fragmented (DCI > 450 mmHg∙cm∙sec) or ineffective (DCI
< 450 mmHg∙cm∙sec) according to the Chicago Classification v3.0
(Fig. 1).13

between the reviewers were resolved by discussion.
Since study patients had pH-impedance studies performed
both on and off PPI therapy, symptom reflux correlation was first
assessed. Symptoms were considered associated with reflux events if
they occurred within 2 minutes following a reflux event. Symptom
associated probability (SAP) was calculated using the Ghillebert
probability estimate.14 SAP was designated positive if the likelihood
of a chance association between symptoms and reflux events was <
5%, corresponding to P < 0.05 and SAP > 95%. The SAP was
first calculated for pH-detected reflux events, then re-calculated
for all impedance-detected reflux events. Our group has previously
shown that Ghillebert probability estimate correlates very well with
SAP calculated using the Weusten method, with sensitivity of 0.95
and specificity of 0.91.15,16 AET was also recorded, calculated as the
percentage of time the pH was below 4 at the distal esophageal pH
sensor.10,17

pH-Impedance Monitoring
pH-impedance testing was offered in an “open-access” fashion
such that referring physicians decided whether testing was performed on or off antisecretory therapy. Patients tested off therapy
were asked to stop their proton pump inhibitor (PPI) medications
5-7 days prior to the study, and histamine-2 receptor antagonists,
prokinetic medications, and antacids 3 days prior to the study.
After an overnight fast, an experienced nurse positioned the pHimpedance catheter (Sandhill Scientific, Highlands Ranch, CO,
USA) with the distal esophageal pH sensor placed 5 cm proximal
to the lower esophageal sphincter, measured using HRM. During
the data acquisition period, patients recorded meals and activities on
a paper diary and logged symptom events electronically using the
device data recorder. Data were then analyzed with dedicated software (Bioview Analysis, Sandhill Scientific, Highlands Ranch, CO,
USA) with automated calculation of acid exposure time (AET),
reflux episodes, symptom events, and symptom-reflux association
parameters. Each pH-impedance study was scrutinized manually
by 2 reviewers (Amit Patel and C Prakash Gyawali) to ensure the
accuracy of automated capture of reflux events; any discrepancies

A

Symptom Burden
Patients reported symptom burden prior to pH-impedance
monitoring both for dominant presenting symptom and global
esophageal symptoms. Symptom frequency and severity were rated
on 5-point Likert scales generated a priori for esophageal testing
at our center and validated for assessment of esophageal symptom.10,11,18,19 For each esophageal symptom, patients rated symptom
frequency from 0 (no symptoms) to 4 (very severe symptoms); the
product of severity and frequency yielded a total score from 0 to 16.
We have previously reported this as dominant symptom intensity.10,11
However, for the purpose of this study, symptom intensity was calculated for each esophageal symptom reported by the patients, re-
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Figure 1. High-resolution manometry Clouse plots demonstrating (A) intact peristaltic contour in an effective swallow, (B) fragmented sequence

with a long (> 5 cm) break, and (C) ineffective sequence with a long break.
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gardless of whether the symptom was dominant or secondary, hence
this is termed esophageal symptom intensity (ESI). Patients rated
their global symptom severity (GSS) pertaining to the esophagus
over the previous 2 weeks on a 100-mm visual analog scale. Basic
demographic data (age, gender, and race) were also collected.
Eligible subjects were prospectively contacted to assess management approaches (surgical versus medical therapy) and symptomatic outcomes, and post-therapy symptom questionnaire data was
required for evaluation of treatment outcome. The pre-procedure
symptom survey was re-administered at this follow-up, and linear as
well as dichotomous (≥ 50%) improvement in ESI and GSS were
calculated to quantify symptomatic outcomes. Each patient’s treating physician guided management with no influence from study
investigators.

Statistical Methods
Data are reported as the mean ± standard error of the mean
unless otherwise indicated. Demographics, PPI status on testing,
baseline symptom burden (ESI and GSS), change in symptom
burden with treatment, SAP, and presence of specific reflux symptoms (heartburn, regurgitation, chest pain, cough, dysphagia, and
laryngeal symptoms) were compared between patients with and
without long breaks in the peristaltic contour. Categorical data were
compared using the χ-squared test, and continuous data were compared using ANOVA, 2-tailed Student’s t test, or Mann-Whitney
U test as appropriate. In all cases, P < 0.05 was required for statistical significance. All statistical analyses were performed using IBM
SPSS Statistics V.22.0 (Armonk, NY, USA).

Results
Of 302 patients undergoing HRM in conjunction with ambulatory pH-impedance monitoring for GERD symptoms, inclusion
criteria were met by 218 patients (53.2 ± 0.9 years, 68.3% female;
Fig. 2). Presenting symptoms included both typical symptoms
(heartburn: 64.2%, regurgitation: 48.6%), and atypical symptoms
(chest pain: 30.7%, cough: 35.8%, dysphagia: 17.4%, laryngeal
symptoms: 11.0%); 168 patients (77.1%) reported > 1 symptom.
When dominant symptoms were segregated into typical (123
[56.4%]) and atypical groups (95 [43.6%]), baseline ESI was
higher in atypical presentations (P = 0.012; Table 1) but global
symptom burden was similar between these 2 groups (P = 0.243);
AET was higher with typical presentations (P = 0.022). There
were no significant differences in demographic, motor diagnoses
or pH impedance metrics between patients with and without long
breaks (P > 0.1 for all comparisons); in particular, we did not demonstrate differences in symptom reflux association metrics between
patients with and without long breaks.
The relationships between individual presenting symptoms and
peristaltic breaks were further assessed. Cough was seen more often
as a presenting symptom in patients tested off PPI therapy (48/111,
43.2%) compared to those tested on therapy (30/107, 28%; P =
0.020). Patients with cough tested off PPI had higher total acid exposure times compared to those tested on PPI (5.3 ± 0.8 vs 0.9 ±
0.3, P < 0.001). Despite this, overall symptom burden was similar
between patients tested off vs on PPI therapy (ESI: 9.3 ± 0.6 vs 8.8

302 pH-impedance studies in
5-year study period
84 Patients ineligible
7 incomplete pH-impedance studies
48 incomplete HRM studies
3 motor disorders
26 prior surgery
218 Patients included
53.2 + 0.9 yr, 68.3% F
111 (50.9%) tested off PPI

Atypical symptoms (n = 95)
54.6 + 1.3 yr, 61% F

Typical symptoms (n = 123)
52.1 + 1.1 yr, 74% F
159 Reached for follow-up
54.4 + 1.0, 70% F
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Figure 2. Flow chart describing the
study population. HRM, high-resolution manometry; F, female; PPI, proton
pump inhibitor.
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Table 1. Comparison of Clinical Characteristics Between Typical and

Atypical Symptoms
Clinical characteristics

Typical
symptoms
(n = 123)

Age (yr)
Gender (% female)
Baseline ESI
Baseline GSS
AET total (%)
IEM
Fragmented peristalsis
Normal peristalsis
Swallows with long breaks

52.1 ± 1.1
74
8.1 ± 0.6
60.8 ± 2.7
4.4 ± 0.5
37 (30%)
1 (1%)
85 (69%)
2.0 ± 0.3

Atypical
symptoms
(n = 95)

P -values

54.6 ± 1.3
0.151
61
0.056
10.3 ± 0.7
0.011
65.7 ± 3.1
0.243
2.8 ± 0.4
0.022
18 (19%)
0.507
1 (1%) > 0.99
72 (76%)
0.291
1.7 ± 0.3
0.313

ESI, esophageal symptom intensity; GSS, global symptom severity; AET, acid
exposure time; IEM, ineffective esophageal motility.

Table 2. Comparison of Clinical Characteristics Between Patients
With and Without Cough

Clinical characteristics

Cough
(n = 78)

Age (yr)
Gender (% female)
Baseline ESI
Baseline GSS
AET total (%)
IEM
Fragmented peristalsis
Normal peristalsis
Swallows with long breaks

51.3 ± 1.1
67
10.5 ± 0.7
67.3 ± 3.5
3.6 ± 0.5
24 (31%)
1 (1%)
53 (68%)
2.4 ± 0.3

No cough
(n = 140)

P -values

56.7 ± 1.4
0.002
69
0.762
8.3 ± 0.5
0.018
60.4 ± 2.5
0.111
3.7 ± 0.5
0.892
35 (25%)
0.427
1 (1%) > 0.99
100 (71%)
0.644
1.6 ± 0.2
0.031

ESI, esophageal symptom intensity; GSS, global symptom severity; AET, acid
exposure time; IEM, ineffective esophageal motility.

Predictors of linear ESI change
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Figure 3. Proportion of breaks in patients with cough. More patients
with cough had long (> 5 cm) breaks in the peristaltic contour compared to patients without cough (*P = 0.024). Numbers of swallows
with breaks was also significantly higher in patients with cough (**P =
0.021).

± 0.6 respectively, GSS: 62.6 ± 3.0 vs 63.3 ± 2.8 respectively, P
> 0.6 for each comparison). Further, PPI status had no bearing on
esophageal motor pattern based on the Chicago classification v3.0 (P
> 0.8 for each comparison).
Patients with cough were significantly more likely than those
without cough to have long breaks in the peristaltic contour (59.0%
vs 42.8%, P = 0.024; Fig. 3); this did not differ whether testing
was performed off or on PPI status. The odds ratio of cough as a
presenting symptom in the setting of breaks was 1.9 (95% confidence interval: 1.1-3.4, P = 0.023); none of the other presenting
symptoms were similarly associated (odds ratios 0.73-1.03, P ≥
0.3). The average number of swallows with long breaks was higher

Figure 4. Predictors of symptom change from antireflux therapy. On

multivariate linear regression, the presence of long breaks was a predictor of suboptimal symptom outcome from antireflux therapy in patients with cough (*P = 0.010). ESI, esophageal symptom intensity;
PPI, proton pump inhibitor; AET, acid exposure time; SAP, symptom
association probability.

in patients with cough compared to patients without cough (2.4 ±
0.3 vs 1.6 ± 0.2, P = 0.021; Fig. 3). Although the average length
of peristaltic breaks was similar between patients presenting with
and without cough (7.6 ± 0.5 cm vs 8.1 ± 0.4 cm, P = 0.496), the
likelihood of fragmented sequences were higher with cough (21.8%
vs 10.7%, P =0.044). Despite this, the proportion of patients classified with ineffective esophageal motility (IEM) was similar. None
of other typical or atypical presenting symptom was associated with
breaks in this fashion. Mean DCI, numbers of ineffective swallows,
and proportions with IEM were similar regardless of presenting
symptom. Cough patients were slightly older and had higher baseline symptom burden, but were otherwise similar to patients without
cough (Table 2).
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Symptom Outcomes
One hundred and fifty-nine patients were successfully contacted to assess symptom outcome after 36.1 ± 1.2 months. Overall, ESI decreased by 5.3 ± 0.5 and GSS by 35.2 ± 2.8. Though
patients with atypical symptoms had a higher baseline ESI than
those with typical symptoms (10.3 ± 0.7 vs 8.1 ± 0.6, P = 0.012),
GSS was similar between the groups, and there was no difference
in degree of improvement in symptom burden with treatment. The
presence or absence of long breaks did not predict symptom burden
or change in symptoms in the overall cohort.
Independent of reflux parameters, the presence of long breaks
with cough as a presenting symptom was a negative predictor for
ESI change with antireflux therapy (ESI improvement of 4.9 ±
0.9) compared to patients without long breaks (ESI improvement
of 8.9 ± 1.4, P = 0.018). GSS improvement was similar regardless
of the presence of breaks (39.9 ± 5.8 vs 44.6 ± 8.4 respectively, P
= 0.639). The presence or absence of long breaks did not predict
improvement in ESI or GSS in a similar fashion with presenting
symptoms other than cough (P ≥ 0.3 for each comparison).
A multivariate regression model was generated using the presence of long breaks, age, gender, PPI status, abnormal AET, and
positive SAP as independent variables, and changes in ESI and
GSS as the outcome variables. In this model, long breaks retained
significance as an independent predictor of suboptimal treatment
outcome within the cough cohort following antireflux therapy, by
ESI but not GSS (Fig. 4). This significance did not hold true for
any other typical or atypical reflux symptoms (P ≥ 0.2 for each
comparison).

Discussion
In this study, we demonstrate that patients with long breaks in
the esophageal peristaltic contour on HRM were more likely to
have cough as a presenting symptom compared to other typical and
atypical symptoms. Conversely, patients with cough were more likely to have swallows with long breaks in the peristaltic contour, and
had a higher number of swallows with breaks. These findings were
independent of esophageal reflux burden, numbers of reflux events,
or symptom-reflux association with cough events on ambulatory reflux monitoring. Our findings validate the report by Almansa et al7
that weak peristalsis with long breaks is encountered with chronic
cough; we further report that this association is not replicated with
other typical or atypical symptoms evaluated with pH-impedance
monitoring. Finally, our findings suggest that patients with cough
392

and long breaks have worse symptomatic outcomes with antireflux
therapy compared to patients with cough without long breaks, or
patients with other esophageal symptoms, with or without long
breaks.
The significance of breaks in the peristaltic contour on esophageal HRM has been extensively debated. The presence of breaks
on combined HRM and impedance testing has been reported to
be associated with dysphagia and incomplete bolus clearance20,21;
in contrast, small breaks are associated with complete bolus clearance and are of questionable clinical significance.22 Weak peristalsis
with long breaks is reported to be associated with increased acid
exposure and delayed reflux clearance.6 Although the Chicago classification v3.0 recognizes long breaks only in the context of DCI >
450 mmHg∙cm∙sec (fragmented sequences),13 there is evidence to
suggest that bolus transit is incomplete with long breaks in general,
regardless of vigor of remnant contraction in the esophagus.7,21
Both fragmented and ineffective sequences (where DCI < 450
mmHg∙cm∙sec regardless of breaks) are associated with GERD in
general, and especially more profound manifestations of GERD
such as Barrett’s esophagus.23,24 While the Chicago classification
does not have an IEM category with long breaks, Almansa et al7
report that this phenotype may be associated with abnormal bolus
clearance, likely from bolus escape through the break. Our findings
therefore add to the growing body of evidence supporting a link between long breaks and esophageal symptoms, particularly in cough
as a presenting symptom.6,7
The precise mechanism of symptom generation from reflux
of gastric content is unclear. Both chemical and mechanical receptors participate in reflux symptom generation, especially heartburn
and chest pain. Cough in particular is thought to have 2 separate
mechanisms leading to symptom generation–aspiration of refluxate into the trachea (likely infrequent), and triggering of a reflexive
cough from esophageal stimulation from the refluxate (likely more
prevalent). Abnormal upper esophageal sphincter function and
esophageal dysmotility have been correlated with chronic cough
and positive symptom association in cough patients.25 Using pHimpedance monitoring, more proximal migration of reflux events
has been found to be associated with higher perception of heartburn and regurgitation.26,27 Afferent sensory nerve endings have
been demonstrated to be more superficially located in the proximal
esophagus,8 potentially explaining higher perception in the precise
area where we report long breaks in the peristaltic contour. Peristaltic defects in the transition zone between the proximal and distal
esophagus are associated with impaired bolus clearance and are
common regardless of whether IEM is confirmed.28 Therefore, it is
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possible that breaks are associated with prolonged refluxate contact
from incomplete reflux clearance in the more perceptive proximal
esophagus, leading to cough as a symptom. We demonstrate that
cough patients with breaks in the peristaltic contour have a less
robust response to antireflux therapy, potentially related to inability
to clear refluxate despite reduced acid exposure. Our study was
not designed to evaluate these proposed mechanisms for symptom
generation, but our findings support a higher likelihood of lack of
contractile activity in the proximal and mid esophagus in patients
with cough.
The current study has a few important limitations. Patients
included in this cohort were identified retrospectively from the
original prospectively collected database, and therefore, the study
is subject to limitations associated with retrospective studies. We
do not have data on the nature of evaluation of chronic cough, and
whether all alternate possibilities were rigorously excluded prior to
esophageal physiologic testing. Symptom-reflux association with
cough as a presenting symptom is difficult, since patients may not
activate event monitor buttons in a timely fashion, particularly when
cough is frequent or paroxysmal29; a cough event monitor was not
utilized in this study. Patient management was directed by treating
physicians, and therefore there was no standard protocol employed
for GERD management, which could have affected our outcome
data. We also do not have post treatment esophageal function testing to determine if breaks resolved or if pH impedance metrics
changed in responders in contrast to non-responders. Our patient
population consists of individuals evaluated at a tertiary care center,
and therefore our results may not be generalizable to primary care
populations. Nevertheless, our findings are in concert with prior
reports linking long breaks to cough as a presenting symptom in the
setting of reflux evaluation, and therefore support further research
into understanding the relationship between esophageal symptoms
and motor patterns.
We conclude that analyzing esophageal motor patterns beyond
what Chicago classification v3.0 encompasses has clinical utility,
particularly in the prediction of symptom response in patients with
cough. What is evident from our findings and other studies in the
literature is that cough is a complex symptom with links to esophageal motor function. Despite this, treating concurrent reflux does
not appear sufficient to resolve this symptom. While the precise
pathophysiologic basis of the association between cough and long
breaks is unclear, existing esophageal pathophysiologic data may
imply impaired reflux clearance in triggering symptoms. Further
prospective research evaluating esophageal symptom generation in
the context of typical and atypical reflux symptoms is needed.
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